Invega (paliperidone) as a new atypical antipsychotic for schizophrenia

You'll hear about Invega (paliperidone) as a new atypical antipsychotic for schizophrenia.

Health Canada is reviewing it now.

But the ingredient in Invega is not really that new...it's the active metabolite of risperidone (Risperdal).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote